Delivery Order SPE2DB25D3201-SPE2DB26FNNXD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of IMFINZI 500 mg/10 mL vials with a ceiling value of $33,544.68 and a firm fixed price structure. The order is scheduled for completion by November 28, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This non-set-aside award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of IMFINZI 500 mg/10 mL vials with a ceiling value of $15,915.42. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is to be completed by July 11, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $7,957.71 to AmerisourceBergen Drug Corp for IMFINZI 500 mg/10 mL vials on August 21, 2025, with completion expected by September 12, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's Conshohocken, Pennsylvania location. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of IMFINZI 500 mg/10 ml vials with a ceiling value of $53,051.40 and a firm fixed price contract type. The order is scheduled for completion by September 29, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order was competitively awarded with no set-aside designation and represents a child contract under...
- The Defense Logistics Agency awarded a Delivery Order contract to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of IMFINZI 500 mg/10 mL vials with a ceiling value of $7,957.71 and an ultimate completion date of October 7, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded through competitive procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency's Medical Supply Chain awarded a $23,873.04 delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of IMFINZI 500 mg/10 mL vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 6, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania location. The award was made without a set-aside designation, reflecting open competition among qualified vendors. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of IMFINZI (an oncology medication) in 120 mg/2.4 mL vials with a ceiling value of $6,344.80. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of September 17, 2025. The delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of IMFINZI 500 mg/10 mL vials with a ceiling value of $18,567.99 and a firm fixed price structure. This non-competitive delivery order is set to be completed by June 25, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract carries no set-aside designation, indicating that it was awarded...
- The Defense Logistics Agency awarded a $23,873.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of IMFINZI (500 mg/10 mL vials). The contract was completed without set-aside designation through open competition and is scheduled for ultimate completion by October 21, 2025. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $21,220.56 to AmerisourceBergen Drug Corp for the supply of IMFINZI 500 mg/10 mL vials. This firm fixed price delivery order, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, represents a non-competitive set-aside award to the pharmaceutical distributor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB26FNNXDDelivery Order
The Defense Logistics Agency awarded a $15,915.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of IMFINZI 500 mg/10 mL vials. The award, which is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), carries an ultimate completion date of December 1, 2025. The contract was competitively awarded with no set-aside designation, and performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, one of the nation's leading pharmaceutical distributors, supplies a comprehensive range of medical products to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. This delivery order for IMFINZI, an oncology therapeutic, reflects the contractor's critical role in supporting military healthcare programs with specialized pharmaceuticals. The firm fixed-price structure and compressed delivery timeline underscore DLA's need for rapid pharmaceutical procurement to support ongoing medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.9k | 11/6/25 |